The Saltzman Research Group at Yale is working with Ingenium Therapeutics in Korea to create technology for producing anti-cancer CAR-NK cells directly in the body. Yale’s “Proteinplex” gene delivery technology will be used in this project to improve cancer therapy.
Team Members
W. Mark Saltzman (PI)
Goizueta Foundation Professor of Biomedical Engineering
Chang-Hee Whang
Professor at University of Mississippi
Xianzhi Zhang
Postdoctoral Associate
Ju Hyun Lee
Ph.D. Student
Nara Chung
Ph.D. Student
